Imunon, Inc.
IMNNNext catalyst
IMNN-001
Epithelial Ovarian Cancer
Get an email about IMNN's next catalysts
Track Imunon (IMNN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (earnings).See the timeline
2 upcoming, 0 past
IMNN Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.61 | FQ end Sep/2026 | Call: bmo
IMNN-001 Phase 2 Est. Readout (MRD)
Estimated primary completion for IMNN-001 trial (NCT05739981) in Ovarian Cancer. Topline data typically follows completion by weeks to months.
SourceMarket Overview
Stock performance and key metrics
IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer)
Epithelial Ovarian Cancer
ThermoDox
Hepatocellular Carcinoma
Dextrose
Hepatocellular Carcinoma
IMNN-101
SARS CoV 2 Infection
ThermoDox in combination with Microwave Hyperthermia (heat)
Breast Cancer
IMNN-001
Epithelial Ovarian Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IMNN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer) | Phase 3 | Epithelial Ovarian Cancer | - | - |
ThermoDox | Phase 3 | Hepatocellular Carcinoma | - | - |
Dextrose | Phase 3 | Hepatocellular Carcinoma | - | - |
IMNN-101 | Phase 2 | SARS CoV 2 Infection | - | - |
ThermoDox in combination with Microwave Hyperthermia (heat) | Phase 2 | Breast Cancer | - | - |
IMNN-001 | Phase 2 | Epithelial Ovarian Cancer | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Imunon, Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in Imunon, Inc.'s (IMNN) pipeline across Phase 3, Phase 2. Its lead program is Dextrose (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Imunon, Inc.'s next FDA catalyst?→
Imunon, Inc.'s (IMNN) next tracked catalyst is a Phase 2 readout expected Q2 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track IMNN biotech catalysts?→
Add IMNN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Imunon, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.